115 related articles for article (PubMed ID: 70413)
21. Terminal deoxynucleotidyl transferase activity in blastic phase of chronic myelogenous leukemia.
Srivastava BI; Khan SA; Minowada J; Gomez GA; Rakowski I
Cancer Res; 1977 Oct; 37(10):3612-8. PubMed ID: 269010
[No Abstract] [Full Text] [Related]
22. Biochemical and immunological properties of human terminal deoxynucleotidyl transferase purified from blasts of acute lymphoblastic and chronic myelogenous leukemia.
Deibel MR; Coleman MS; Acree K; Hutton JJ
J Clin Invest; 1981 Mar; 67(3):725-34. PubMed ID: 6937474
[TBL] [Abstract][Full Text] [Related]
23. Chronic myelocytic leukemia terminating in blast cell crisis with lymphoblastic characteristics.
Walters TR; Minowada J; Tsubota T; Kataoka K; Han T
Pediatrics; 1978 Nov; 62(5):795-800. PubMed ID: 281667
[TBL] [Abstract][Full Text] [Related]
24. Terminal transferase as a predictor of initial responsiveness to vincristine and prednisone in blastic chronic myelogenous leukemia: a co-operative study.
Marks SM; Baltimore D; McCaffrey R
N Engl J Med; 1978 Apr; 298(15):812-4. PubMed ID: 273142
[TBL] [Abstract][Full Text] [Related]
25. Antigenic relationships in calf thymus and human leukemic cell terminal deoxynucleotidyl transferase.
Chan JY; Srivastava BI
Biochim Biophys Acta; 1976 Oct; 447(3):353-9. PubMed ID: 1067872
[TBL] [Abstract][Full Text] [Related]
26. Evolution of cultured leukemic cell lines monitored by chromosomal and immunologic analysis.
Hozier J; Lindquist L; Hurwitz R; LeBien T; Kersey J
Int J Cancer; 1980 Sep; 26(3):281-4. PubMed ID: 6945291
[TBL] [Abstract][Full Text] [Related]
27. Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis.
Shumak KH; Baker MA; Taub RN; Coleman MS
Cancer Res; 1980 Nov; 40(11):4048-52. PubMed ID: 6937237
[TBL] [Abstract][Full Text] [Related]
28. Terminal deoxynucleotidyl transferase activity in neoplastic and nonneoplastic hematopoietic cells.
Bearman RM; Winberg CD; Maslow WC; Racklin B; Carlson F; Nathwani BN; Kim H; Diamond LW; Fallis B; Rappaport H
Am J Clin Pathol; 1981 Jun; 75(6):794-802. PubMed ID: 7020399
[TBL] [Abstract][Full Text] [Related]
29. Myeloperoxidase positive acute lymphoblastic leukemia cell lines, NALM-30, NALM-31 and NALM-32, carrying Philadelphia chromosome with biphenotypic characteristics.
Matsuo Y; Sugimoto A; Harashima A; Nishizaki C; Drexler HG; Orita K
Hum Cell; 1998 Dec; 11(4):221-30. PubMed ID: 10363160
[TBL] [Abstract][Full Text] [Related]
30. Clinical utility of leukemia cell terminal transferase measurements.
McCaffrey R; Lillquist A; Sallan S; Cohen E; Osband M
Cancer Res; 1981 Nov; 41(11 Pt 2):4814-20. PubMed ID: 7028251
[TBL] [Abstract][Full Text] [Related]
31. Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma.
Schneider U; Schwenk HU; Bornkamm G
Int J Cancer; 1977 May; 19(5):621-6. PubMed ID: 68013
[TBL] [Abstract][Full Text] [Related]
32. Strong, specific anti-human leukemia antisera prepared with the use of purified cell membrane antigen.
Negoro S; Seon BK
Cancer Res; 1981 Jul; 41(7):2973-6. PubMed ID: 6972802
[TBL] [Abstract][Full Text] [Related]
33. Terminal deoxynucleotidyl transferase in a case of childhood acute lymphoblastic leukemia.
McCaffrey R; Smoler DF; Baltimore D
Proc Natl Acad Sci U S A; 1973 Feb; 70(2):521-5. PubMed ID: 4346893
[TBL] [Abstract][Full Text] [Related]
34. Expression of an antigen associated with acute lymphoblastic leukemia in human leukemia-lymphoma cell lines.
Minowada J; Janossy G; Greaves MF; Tsubota T; Srivastava BI; Morikawa S; Tatsumi E
J Natl Cancer Inst; 1978 Jun; 60(6):1269-77. PubMed ID: 206705
[No Abstract] [Full Text] [Related]
35. Identification of a leukemia-associated antigen of human acute lymphocytic leukemia.
Veit BC; Melvin SL; Bowman WP
J Natl Cancer Inst; 1980 Jun; 64(6):1321-8. PubMed ID: 6154821
[TBL] [Abstract][Full Text] [Related]
36. Clinical utility of terminal deoxynucleotidyl transferase and adenosine deaminase determinations in adult leukemia with a lymphoid phenotype.
Brusamolino E; Isernia P; Lazzarino M; Scovassi I; Bertazzoni U; Bernasconi C
J Clin Oncol; 1984 Aug; 2(8):871-80. PubMed ID: 6589363
[TBL] [Abstract][Full Text] [Related]
37. B-cell maturation stages of Burkitt's lymphoma cell lines according to Epstein-Barr virus status and type of chromosome translocation.
Cohen JH; Revillard JP; Magaud JP; Lenoir G; Vuillaume M; Manel AM; Vincent C; Bryon PA
J Natl Cancer Inst; 1987 Feb; 78(2):235-42. PubMed ID: 3027441
[TBL] [Abstract][Full Text] [Related]
38. Terminal deoxynucleotidyl transferase and human leukemia.
Sahai Srivastava BI
Res Commun Chem Pathol Pharmacol; 1975 Apr; 10(4):715-24. PubMed ID: 1153847
[TBL] [Abstract][Full Text] [Related]
39. Bi-phenotypic t(9;22)-positive leukemia cell lines from a patient with acute leukemia: NALM-20, established at the onset; and NALM-21, NALM-22 and NALM-23, established after relapse.
Matsuo Y; Ariyasu T; Ohmoto E; Kimura I; Minowada J
Hum Cell; 1991 Dec; 4(4):335-8. PubMed ID: 1817649
[TBL] [Abstract][Full Text] [Related]
40. Establishment of an Epstein-Barr virus-determined nuclear antigen-negative human B-cell line from acute lymphoblastic leukemia.
Hiraki S; Miyoshi I; Masuji H; Kubonishi I; Matsuda Y
J Natl Cancer Inst; 1977 Jul; 59(1):93-4. PubMed ID: 195075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
